Skip to main content
. 2023 May 23;115(9):1109–1111. doi: 10.1093/jnci/djad086

Figure 1.

Figure 1.

Trends in delay-adjusted age‐standardized incidence rates for all cancer sites combined, melanoma and male prostate cancer using the Surveillance, Epidemiology, and End Results (SEER)-22. A) November 2021 data submission (2000-2019), B) November 2022 data submission (2000-2020), and C) November 2022 data submission (2000-2019), thus excluding 2020 data. An asterisk (*) indicates that the annual percent change (APC) is statistically significantly different from zero (P < .05).